Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02129985
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02129985
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02129985. Randomized; no masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
- Acronym
- T2DMRS
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Exenatide
- Intervention (Drug)
- Metformin
- Lead sponsor
- xiaolong zhao
- Collaborator
- Shanghai Zhongshan Hospital
- Collaborator
- The third people's Hospital Affiliated to Shanghai Jiao Tong University
- Collaborator
- Second Affiliated Hospital of Soochow University
- Collaborator
- The First Hospital of Guiyang Medical college
- Collaborator
- Fuling Central Hospital of Chongqing City
- Collaborator
- Taizhou Hospital
- Collaborator
- Shanghai Pudong New Area Gongli Hospital
Record details
- Record id
cardio:ct-nct02129985- Content hash
6df9fe033696ed7970e24ef327c3b37969aba054735adc27ba362ef259eb23e4